Literature DB >> 28780374

Maternal T and B cell engraftment in two cases of X-linked severe combined immunodeficiency with IgG1 gammopathy.

Tsubasa Okano1, Takuro Nishikawa2, Eri Watanabe3, Takashi Watanabe4, Takehiro Takashima1, Tzu-Wen Yeh1, Motoi Yamashita1, Mari Tanaka-Kubota1, Satoshi Miyamoto1, Noriko Mitsuiki1, Masatoshi Takagi5, Yoshifumi Kawano2, Yoshiki Mochizuki4, Kohsuke Imai6, Hirokazu Kanegane7, Tomohiro Morio1.   

Abstract

X-linked severe combined immunodeficiency (X-SCID), caused by defects in the common gamma chain, is typically characterized by T and NK cell defects with the presence of B cells. T cell dysfunction and impaired class-switch recombination of B cells mean that patients typically have defects in class-switched immunoglobulins (IgG, IgA, and IgE) with detectable IgM. Here, we describe two patients with X-SCID with IgG1 gammopathy, in whom we identified maternal T and B cell engraftment. Exclusively, maternal B cells were found among the IgD-CD27+ class-switched memory B cells, whereas the patients' B cells remained naïve. In vitro stimulation with CD40L+IL-21 revealed that peripheral blood cells from both patients produced only IgG1. Class-switched maternal B cells had restricted receptor repertoires with various constant regions and few somatic hypermutations. In conclusion, engrafted maternal B cells underwent class-switch recombination and produced immunoglobulin, causing hypergammaglobulinemia in patients with X-SCID.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allotype; Gammopathy; Germinal center; Hypergammaglobulinemia; IL2RG; Maternal engraftment; Memory B cell; Multiple myeloma; Somatic hypermutation; X-linked severe combined immunodeficiency

Mesh:

Substances:

Year:  2017        PMID: 28780374     DOI: 10.1016/j.clim.2017.08.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  4 in total

1.  Droplet Digital PCR-Based Chimerism Analysis for Primary Immunodeficiency Diseases.

Authors:  Tsubasa Okano; Yuki Tsujita; Hirokazu Kanegane; Kanako Mitsui-Sekinaka; Kay Tanita; Satoshi Miyamoto; Tzu-Wen Yeh; Motoi Yamashita; Naomi Terada; Yumi Ogura; Masatoshi Takagi; Kohsuke Imai; Shigeaki Nonoyama; Tomohiro Morio
Journal:  J Clin Immunol       Date:  2018-04-18       Impact factor: 8.317

Review 2.  Somatic genetic rescue in Mendelian haematopoietic diseases.

Authors:  Patrick Revy; Caroline Kannengiesser; Alain Fischer
Journal:  Nat Rev Genet       Date:  2019-06-11       Impact factor: 53.242

3.  Case Report: Rotavirus Vaccination and Severe Combined Immunodeficiency in Japan.

Authors:  Kay Tanita; Yoshiki Kawamura; Hiroki Miura; Noriko Mitsuiki; Takahiro Tomoda; Kento Inoue; Akihiro Iguchi; Masafumi Yamada; Taro Yoshida; Hideki Muramatsu; Norimasa Tada; Toshihiro Matsui; Motohiro Kato; Katsuhide Eguchi; Masataka Ishimura; Shouichi Ohga; Kohsuke Imai; Tomohiro Morio; Tetsushi Yoshikawa; Hirokazu Kanegane
Journal:  Front Immunol       Date:  2022-02-23       Impact factor: 7.561

4.  Hematopoietic cell transplantation for asymptomatic X-linked lymphoproliferative syndrome type 1.

Authors:  Akihiro Tamura; Suguru Uemura; Nobuyuki Yamamoto; Atsuro Saito; Aiko Kozaki; Kenji Kishimoto; Toshiaki Ishida; Daiichiro Hasegawa; Haruka Hiroki; Tsubasa Okano; Kohsuke Imai; Tomohiro Morio; Hirokazu Kanegane; Yoshiyuki Kosaka
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-14       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.